HIV-1膜蛋白抗原优化改造研究进展
摘要
HIV-1的外膜糖蛋白能与T细胞或单核/巨噬细胞表面的CD4受体分子结合,从而起始HIV感染靶细胞的生物学过程。由于HIV-1膜蛋白是中和抗体的主要作用靶位,因此成为HIV疫苗中不可缺少的组分。越来越多的研究表明:天然HIV-1膜蛋白不能激发有效的中和抗体,所以需要对膜蛋白进行优化改造,以提高中和表位的免疫原性。本文就近年来HIV-1膜蛋白抗原优化改造研究做一简要回顾以供参考。
出处
《国际病毒学杂志》
2007年第2期49-54,共6页
International Journal of Virology
参考文献48
-
1Edward A. Belongia, and Allison L. Naleway. Smallpox Vaccine:The Good, the Bad, and the Ugly. Clin Med Res 2003; 1(2) : 87-92.
-
2Koch M, Pancera M, Kwong PD, et al. Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition. Virology 2003; 313: 387-400.
-
3Freed EO,Risser R. The role of envelope glycoprotein processing in murine leukemia virus infection. J Virol 1987; 61: 2852-2856.
-
4Wyatt R. , Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 1998; 280 (5371) : 1884-1888.
-
5Kwong PD, Wyatt R, Robinson J, et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998; 393(6686) : 648-659.
-
6Cheryl AP. Glycosylation of the ENV Spike of Primate Immunodeficiency Virus and Antibody Neutralization. Current HIV Res 2004,2 : 243-254.
-
7McCaffrey RA, Saunders C, Hensel M, et al. N-Linked Glycosylation of the V3 Loop and the Immunologically Silent Face of gp120 Protects Human Immunodeficiency Virus Type 1 SF162 from Neutralization by Anti-gp120 and Anti-gp41 Antibodies. JVI 2003; 78(7) : 3279-3295.
-
8Li Y, Bergeron JJ, Luo L, et al. Effects of inefficient cleavage of the signal sequence of HIV-1 gp120 on its association with calnexin,folding and intracellular transport. PNAS 1996; 93: 9606-9611.
-
9Li Y, Luo L, Rasool N, and Kang CY. Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. JVI 1993; 67: 584-588.
-
10Li Y, Luo L, Thomas DY, and Kang CY. Control of expression,glycosylation and secretion of HIV-1 gp120 by homologous and heterologous signal sequences. Virology 1994; 204: 266-278.
二级参考文献16
-
1Goulder P J, Brander C, Tang Y, et al. Evolution and transmission of stable CTL escape mutations in HIV infection [J ]. Nature, 2001,412:334 - 338.
-
2Chouquet C, Autran B, Gomard E, et al. Correlation between breadth of memory HIV-specific cytotoxic T cells,viral load and disease progression in HIV infection[J]. AIDS,2002,16:2399 - 2407.
-
3Cmarko D, Boe S O, Scassellati C, et al. Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs[J ]. J Virol, 2002,76:10473 - 10484.
-
4Kong W,Tian C J, Liu B D, et al. Stable expression of primary human immunodeficiency virus type 1 structural gene products by use of a noncytopathic Sindbis virus vector[ J ]. J Virol, 2002,76:1143411439.
-
5Zolotukhin A S, Michalowski D, Bear J, et al. PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression[ J ]. Mol Cell Biol,2003,23: 6618 - 6630.
-
6Andre S, Seed B, Eberle J, et al. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage[ J ]. J Virol, 1998,72:1497 - 1503.
-
7Xin K Q, Urabe M, Yang J, et al. A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus[J]. Hum Gene Ther, 2001,12:1047- 1061.
-
8Klinman D M, Yamshchikov G, Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines [ J ]. J Immunol,1997,158: 3635 - 3639.
-
9Letvin NL. Strategies for an HIV vaccine. J Clin Invest,2002, 110: 15-20.
-
10Bruce CB, Akrigg A, Sharpe SA, et al. Replication-deficient recombinant adenoviruses expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice. J Gen Virol, 1999,80:2621-2628.
共引文献8
-
1冯霞,余双庆,陈国敏,吴小兵,左建民,董温平,周玲,曾毅.含HIV-1 gp120基因的重组腺相关病毒和重组腺病毒疫苗联合免疫的研究[J].中华实验和临床病毒学杂志,2004,18(4):312-315. 被引量:2
-
2陈振海,杨汉春,郭鑫,陈艳红.表达伪狂犬病毒gC糖蛋白基因重组腺病毒的构建及其免疫效果[J].农业生物技术学报,2007,15(2):192-197. 被引量:4
-
3张璐,张春华,李军,黄祖瑚,卢山,王世霞.密码子优化的中国HIV-1流行亚型gp120共识序列核酸疫苗的构建及其免疫原性的初步研究[J].南京医科大学学报(自然科学版),2008,28(9):1104-1108. 被引量:2
-
4杜合娟,王世霞,李军,黄祖瑚,卢山,邢益平.密码子优化对乙肝病毒表面抗原中蛋白核酸疫苗免疫原性的影响[J].南京医科大学学报(自然科学版),2009,29(3):286-290.
-
5冯劼,朱娟莉,董兆麟,陈超.HIV-1外膜蛋白gp120在酵母Pichia pastoris中的表达[J].西北大学学报(自然科学版),2009,39(5):801-804.
-
6余双庆,冯霞,刘红梅,杨海儒,李红霞,曾毅.重组HIV-1 gp120 AAV2/1在小鼠和恒河猴体内的免疫原性[J].病毒学报,2010,26(2):115-120. 被引量:1
-
7白雪,夏厚军,戴正喜,马建平,李少遊,郑永唐.HIV-1 C亚型密码子优化gp120负载人DC疫苗的构建及体外功能[J].免疫学杂志,2010,26(9):741-746.
-
8杜合娟,陆忠华,邢益平.密码子优化对DNA疫苗免疫原性的影响[J].现代生物医学进展,2011,11(24):4996-4998. 被引量:1
-
1杨惠珍,姜昌斌,杨杨,徐克继,钱宗立.弓形虫膜蛋白抗原的研究 Ⅰ.虫膜蛋白抗原制备方法的探讨[J].中国寄生虫病防治杂志,1993,6(4):286-287. 被引量:5
-
2赵芝娜,李保强,宋焕景,宋娟,王桂珍.肺炎支原体重组蛋白抗原与膜蛋白抗原诊断试剂在临床应用中的比较[J].中国病原生物学杂志,2009,4(11):804-805. 被引量:1
-
3职宁,俞树荣,张映雪,李芹阶,余国泉.Q热立克次体67kD蛋白的免疫保护性研究[J].中华微生物学和免疫学杂志,1994,14(2):77-80. 被引量:1
-
4卿格非,戴保民.四株钩端螺旋体外膜单克隆抗体的建立、鉴定及对外膜蛋白抗原的分析[J].华西医科大学学报,1989,20(3):257-261. 被引量:6
-
5熊剑辉,李沛涛.空肠/结肠弯曲菌膜蛋白抗原的初步研究[J].湖南医科大学学报,1992,17(2):190-192.
-
6陆丽君,孟锐锋,国强,朱珊丽,张丽芳.EB病毒膜蛋白家兔免疫血清的制备及其特性研究[J].温州医学院学报,2009,39(2):97-100. 被引量:5
-
7陈亮,严延生,翁育伟,王惠榕,于恩庶.查菲埃立克体120kDa抗原蛋白基因的克隆与表达[J].中国人兽共患病杂志,2001,17(4):13-16.
-
8赵世巧,冯文莉.基因治疗的病毒载体研究进展[J].国外医学(临床生物化学与检验学分册),2005,26(10):709-711. 被引量:15
-
9姜春俊,周炜均,谢晓灵,杜静文,张宏毫,贺艳杰,李玉华.Eps8抗原改造表位HLA-A*0201限制性抗肿瘤能力观察[J].山东医药,2016,56(26):1-5.
-
10周惠琼,江立敏,郑夔,顾耀亮,梁文燕,柯昌文.登革病毒重组膜蛋白抗原的制备与应用[J].华南预防医学,2007,33(5):22-25. 被引量:2